Auto-MHC class II-reactive T cell line obtained from MRL mice

从 MRL 小鼠获得的自身 MHC II 类反应性 T 细胞系

基本信息

  • 批准号:
    02670162
  • 负责人:
  • 金额:
    $ 1.47万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1990
  • 资助国家:
    日本
  • 起止时间:
    1990 至 1991
  • 项目状态:
    已结题

项目摘要

Two congenic strains of MRL mice are knwon; MRL/lpr mice possess lpr gene and MRL/+ mice posses wild type gene. Although they are different at the presence of lpr gene, lethally irradiated MRL/+ mice reconstituted with MRL/lpr bone marrow cells develop severe graft-versus-host disease (GVHD)-like syndrome which is known as lpr-GVHD (1). We have established a CD4^+ T cell line (l/+T1) and examined characteristics of l/+T1 cells in vitro and in vivo.1. L/+ T1 cells show prliferative response restricted to self-I-E^k molecule in vitro. B cells show relatively high stimulation activity to l/+T1 cells (2).2. L/+T1 cells can induce proliferation and differentiation of I-E^k B cells, and induce lgM production including autoantibodies (anti-ssDNA antibodies and rheumatoid factors (RF) in vitro (2). 3. Injection of l/+T1 cells to H-2^k mice (MRL/+ and AKR), but not to H-2^d mice, induces enhanced autoreactivity of recipient spleen cells 1 to 2 months after injection. The injection also enhances … More IgG RF prosuction in MRL/+ mice, and slightly IgG and IgM RF production in AKR mice. However, anti-ssDNA antibody production can not be augmented by the injection of l/+ T1 cells, suggesting that autoantibody production is dependent on the presence of antigen (3).4. When MRL/lpr abnormal T cells were co-cultured with l/+ T1 cells,abnormal T cells showed a tendency to convert to CD8^+ T cells. However, the conversion was not so marked comparing with control cultures.5. A hybridoma (25T3, IgM, k) was established from MRL/+ mice immunized with l/+T1 cells. 25T3 monoclonal antibody (mAb) is specific for T cells and reacts with approximately 90% thymocytes. In splenic T cells, approximately 90% CD8^+ cells are positive for 25T3-reactive antigen (25T3-Ag), and CD4^+ T cells are divided to two popualtions by their surface expression of 25T3-Ag; CD4^+25T3-Ag^+ cells relatively correspond to Thl cells and CD4^+25T3^- cel'ls to Th2 cells. 25T3-Ag is approximately 70 kDa by SDS-PAGE. L/+ T1 cells are positive for 25T3-Ag, 25T3 mAb may be useful to analyze autoimmune disease and lpr-GVHD (4). Less
已知MRL小鼠有两个同源品系,MRL/lpr小鼠具有lpr基因,MRL/+小鼠具有野生型基因。尽管它们在lpr基因存在时是不同的,但用MRL/lpr骨髓细胞重建的致死性辐照MRL/+小鼠发生了严重的移植物抗宿主病(GVHD)样综合征,称为lpr-GVHD(1)。我们建立了一个CD 4 ^+ T细胞系(1/+T1),并在体外和体内检测了1/+T1细胞的特性。L/+ T1细胞在体外表现出仅限于自身I-Ek分子的增殖反应。B细胞对1/+T1细胞显示出相对高的刺激活性(2)。L/+T1细胞可以诱导I-E^k B细胞的增殖和分化,并在体外诱导IgM产生,包括自身抗体(抗ssDNA抗体和类风湿因子(RF))(2)。3.将1/+T1细胞注射至H-2k小鼠(MRL/+和AKR),但不注射至H-2d小鼠,在注射后1至2个月诱导受体脾细胞的增强的自身反应性。注射也增强了 ...更多信息 MRL/+小鼠中IgG RF前抽吸,AKR小鼠中轻微IgG和IgM RF产生。然而,抗ssDNA抗体的产生不能通过注射1/+ T1细胞来增强,这表明自身抗体的产生依赖于抗原的存在(3)。当MRL/lpr异常T细胞与1/+ T1细胞共培养时,异常T细胞显示出向CD 8 ^+ T细胞转化的趋势。但转化率与对照组相比并不显著.用1/+T1细胞免疫MRL/+小鼠,建立杂交瘤细胞株(25 T3,IgM,k)。25 T3单克隆抗体(mAb)对T细胞具有特异性,与约90%的胸腺细胞反应。在脾T细胞中,约90%的CD 8 ^+细胞对25 T3-反应性抗原(25 T3-Ag)呈阳性,而CD 4 ^+ T细胞因其表面表达25 T3-Ag而分为两个群体:CD 4 ^+25 T3-Ag^+细胞相对对应于Th 1细胞,CD 4 ^+25 T3 ^-细胞相对对应于Th 2细胞。25 T3-Ag经SDS-PAGE分析约为70 kDa。L/+ T1细胞对25 T3-Ag呈阳性,25 T3 mAb可能有助于分析自身免疫性疾病和lpr-GVHD(4)。少

项目成果

期刊论文数量(17)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
T.Nakagawa,N.Nagata,N.Hosaka,M.Inaba,and s.Ikehara: "Analyses of acute graft-versus-host like reaction in[MRL/lpr→MRL/+]chimeric mice using MRL/lpr-Thy-1.1 congenic mice." Cell.Immunol.137. 189-199 (1991)
T.Nakakawa、N.Nagata、N.Hosaka、M.Inaba 和 s.Ikehara:“使用 MRL/lpr-Thy 分析 [MRL/lpr→MRL/+] 嵌合小鼠中的急性移植物抗宿主样反应-1.1 同类小鼠。”Cell.Immunol.137. 189-199 (1991)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
長田 憲和,池原 進: "免疫毒性と自己免疫" 免疫薬理. 10. (1992)
Norikazu Nagata、Susumu Ikehara:“免疫毒性和自身免疫”免疫药理学 10。(1992)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
N. Nagata, S. Taketani, Y. Adachi, N. Hosaka, S. Miyashima, R. Tokunaga, and S. Ikehara: "A monoclonal antibody reactive with a glycophosphatidylinositol-anchored molecule on T cells defines CD4^+ T cell subsets." Eur. J. Immunol.(1993)
N. Nagata、S. Taketani、Y. Adachi、N. Hosaka、S. Miyashima、R. Tokunaga 和 S. Ikehara:“与 T 细胞上糖磷脂酰肌醇锚定分子发生反应的单克隆抗体定义了 CD4+ T 细胞亚群。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
N.Nagata et al.: "AutoーMHC class IIーreactive T cell line obtained form MRL/+ mice suffering from “lprーGVHD"I.Characterization of surface phenotypes" Immunobiology.
N.Nagata 等人:“从患有“lpr-GVHD”的 MRL/+ 小鼠中获得的 Auto-MHC II 类反应性 T 细胞系。I.表面表型的表征”免疫生物学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
N.Nagata,R.Yasumizu,Y.Ohnishi,T.Nakagawa,M.Inaba,and S.Ikehara: "Auto-MHC Class II-reactive T cell reactive T cell line obtained from MRL/+ mice suffering from “lpr-GVHD".I.Characterization of surface phenotypes,specificities and functions in vitro." Immu
N. Nagata、R. Yasumizu、Y. Ohnishi、T. Nakakawa、M. Inaba 和 S. Ikehara:“自 MHC II 类反应性 T 细胞反应性 T 细胞系从患有“lpr- GVHD“.I.体外表面表型、特异性和功能的表征。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NAGATA Norikazu其他文献

NAGATA Norikazu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NAGATA Norikazu', 18)}}的其他基金

Immunological and molecular biological analyzes of cell surface antigens associated with T cell activation and function
与 T 细胞活化和功能相关的细胞表面抗原的免疫学和分子生物学分析
  • 批准号:
    06670242
  • 财政年份:
    1994
  • 资助金额:
    $ 1.47万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似国自然基金

孤独症动物模型(Fmr1 KO mice)脑功能网络的时空特性研究
  • 批准号:
    31171025
  • 批准年份:
    2011
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目

相似海外基金

DNA Methylation-dependent regulation of Cathepsin E gene expression by the transcription factor Kaiso in MRL/lpr mice
MRL/lpr 小鼠中转录因子 Kaiso 对组织蛋白酶 E 基因表达的 DNA 甲基化依赖性调节
  • 批准号:
    18K16151
  • 财政年份:
    2018
  • 资助金额:
    $ 1.47万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
DNA Methylation-dependent regulation of Cathepsin E gene expression by the transcription factor Kaiso in MRL/lpr mice
MRL/lpr 小鼠中转录因子 Kaiso 对组织蛋白酶 E 基因表达的 DNA 甲基化依赖性调节
  • 批准号:
    16K19601
  • 财政年份:
    2016
  • 资助金额:
    $ 1.47万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Function analysis of MASP-1 as a therapeutic target for lupus-pronenephritis in MRL/lpr mice
MASP-1作为MRL/lpr小鼠狼疮性肾炎治疗靶点的功能分析
  • 批准号:
    23790542
  • 财政年份:
    2011
  • 资助金额:
    $ 1.47万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
IL-18 is essential for the development of autoimmune disease in MRL-Fas^<lpr> mice.
IL-18对于MRL-Fas^<lpr>小鼠中自身免疫性疾病的发展是必需的。
  • 批准号:
    13670484
  • 财政年份:
    2001
  • 资助金额:
    $ 1.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The composition and the pathological significance of C1q-binding immune complexes in MRL/lpr mice
MRL/lpr小鼠C1q结合免疫复合物的组成及其病理意义
  • 批准号:
    09671152
  • 财政年份:
    1997
  • 资助金额:
    $ 1.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
ANTI-SM B CELLS OF MRL/LPR MICE
MRL/LPR 小鼠的抗 SM B 细胞
  • 批准号:
    6100595
  • 财政年份:
    1997
  • 资助金额:
    $ 1.47万
  • 项目类别:
T-CELL ANERGY LOSS TO A SUPERANTIGEN ON MRL-LPR/LPR MICE
MRL-LPR/LPR 小鼠的 T 细胞因超抗原而失去能量
  • 批准号:
    6099645
  • 财政年份:
    1996
  • 资助金额:
    $ 1.47万
  • 项目类别:
IL2 DEFICIENCY MEDIATES AUTOIMMUNITY IN MRL-LPR MICE
IL2 缺乏介导 MRL-LPR 小鼠的自身免疫
  • 批准号:
    2081786
  • 财政年份:
    1993
  • 资助金额:
    $ 1.47万
  • 项目类别:
IL2 DEFICIENCY MEDIATES AUTOIMMUNITY IN MRL-LPR MICE
IL2 缺乏介导 MRL-LPR 小鼠的自身免疫
  • 批准号:
    2081788
  • 财政年份:
    1993
  • 资助金额:
    $ 1.47万
  • 项目类别:
IL2 DEFICIENCY MEDIATES AUTOIMMUNITY IN MRL-LPR MICE
IL2 缺乏介导 MRL-LPR 小鼠的自身免疫
  • 批准号:
    2081787
  • 财政年份:
    1993
  • 资助金额:
    $ 1.47万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了